Back
ESC Professional Premium Access

Development of a new score to predict left ventricular reverse remodelling in patients with nonischemic cardiomyopathy

Session: Non-ischaemic cardiomyopathy: novel insights
Topic: Dilated Cardiomyopathy
Speaker: Doctor M. Ferrandez (Madrid, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marcos Ferrandez

San Carlos Clinical University Hospital, Madrid (Spain)
0 follower

6 more presentations in this session

Natural history of MYH7-related dilated cardiomyopathy

Speaker: Doctor F. de Frutos Seminario (Barcelona, ES)

Access
Abstract
Slides
Like
Thumbnail

Phenotypic variability of FLNC-related cardiomyopathy: insights from a novel Dutch founder variant

Speaker: Mr S. Schoonvelde (Rotterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Natural history and clinical parameters of chemotherapy-induced dilated cardiomyopathy

Speaker: Doctor E. Del Mestre (Trieste, IT)

Access
Abstract
Slides
Like
Thumbnail

Diagnostic pathways leading to arrhythmogenic left ventricular cardiomyopathy in a single center cohort

Speaker: Doctor V. Parisi (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

The joint role of collagen turn-over biomarkers and late gadolinium enhancement to predict cardiovascular outcome in nonischemic dilated cardiomyopathy

Speaker: Doctor A. Zlibut (Cluj Napoca, RO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Non-ischaemic cardiomyopathy: novel insights

Speakers: Doctor M. Ferrandez, Doctor F. de Frutos Seminario, Mr S. Schoonvelde, Doctor E. Del Mestre, Doctor V. Parisi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources